SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-053502
Filing Date
2024-06-18
Accepted
2024-06-18 06:07:27
Documents
6
Period of Report
2024-08-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea0207116-def14a_hoththerap.htm DEF 14A 328181
2 GRAPHIC image_001.jpg GRAPHIC 10072
3 GRAPHIC image_002.jpg GRAPHIC 16828
4 GRAPHIC image_003.jpg GRAPHIC 8973
5 GRAPHIC image_004.jpg GRAPHIC 213269
6 GRAPHIC image_005.jpg GRAPHIC 195997
  Complete submission text file 0001213900-24-053502.txt   876205
Mailing Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 (646)756-2997
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38803 | Film No.: 241050117
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)